NCT06409013Recruiting
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 75 (estimated)
- First submitted
- 7 May 2024
- Start date
- 14 Mar 2024
- Primary completion date
- 30 Mar 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Sarcoma
- NCT number
- NCT06409013
What you commit to
- Study type: Observational
- Planned participants: 75
- From 14 Mar 2024 to the primary completion date, 30 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic kidney disease
Other
- Anaphylaxis to dyes
Who the study is looking for
- Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.